Literature DB >> 24555431

Hypoxia upregulates MAPK(p38)/MAPK(ERK) phosphorylation in vitro: neuroimmunological differential time-dependent expression of MAPKs.

John J Haddad, Lama B Hanbali1.   

Abstract

In mammalian cells, responses to hypoxia at the molecular transduction level are hallmarks of adaptation and survival under oxygen deprivation conditions. In this study, the protein expression patterns of mitogen-activated protein kinases (MAPKs) are investigated under hypoxia in primary cortical neurons and in a model of organotypic hippocampal slices in neonatal Sprague-Dawley rats. Abrupt fluctuations in MAPK expression can occur during anoxia, hypoxia, and relative hyperoxic shifts (e.g., reoxygenation); therefore, phosphorylation and dephosphorylation states could be crucial factors in metabolic reorganization for withstanding anaerobiosis. Whole cellular protein extracts were analyzed for the phosphorylation of MAPKp(p38) and MAPK(ERK-1/2 (p44/p42)) at threonine and tyrosine residues (Thr(180)/Tyr(182)) at different time periods of hypoxic exposure relative to a fixed normoxia control. The phospho-MAPK(p38) (p-MAPK(p38)) to MAPK(p38) relative unit ratio revealed that MAPK(p38) expression increased in cortical neurons after 5 and 10 min, but decreased abruptly afterwards (20 - 120 min). The expression of phospho-MAPK(ERK-1) (p-MAPK(ERK-1/p44)), however, decreased whereas that of p-MAPK(ERK-2/p42) increased compared to normoxia. In rat hippocampal slices (RHS), the expression of p-MAPK(p38) was slightly but significantly higher in hypoxia, whereas the expression of p-MAPK(ERK-2/p42) increased and that of p-MAPK(ERK-1/p44) was intangible. This indicates that in cortical neurons hypoxia differentially upregulated the phosphorylation activation states of MAPK(p38) and MAPK(ERK-1/2 (p44/p42)), whereas in the RHS model MAPK(p38) and MAPK(ERK-2/p42), but not MAPK(ERK-1/p44), phosphorylation states were upregulated in response to hypoxia. The neuroimmunological molecular patterns of the differential MAPK phosphorylation in vitro and ex vivo in response to hypoxic shift indicated a significant role for these kinases in cellular adaptation to oxygen deprivation, and thereby may identify physiologic and neuroprotective responsive signaling cofactors and pathways in cortical and hippocampal neurons during hypoxia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24555431     DOI: 10.2174/092986652105140218112521

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  5 in total

1.  GYY4137 stimulates osteoblastic cell proliferation and differentiation via an ERK1/2-dependent anti-oxidant mechanism.

Authors:  Meng Lv; Yang Liu; Ting-Hui Xiao; Wei Jiang; Bo-Wen Lin; Xiao-Ming Zhang; Yi-Miao Lin; Zhong-Shi Xu
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

2.  γ₁34.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia.

Authors:  G K Friedman; L Nan; M C Haas; V M Kelly; B P Moore; C P Langford; H Xu; X Han; E A Beierle; J M Markert; K A Cassady; G Y Gillespie
Journal:  Gene Ther       Date:  2014-11-27       Impact factor: 5.250

3.  MCPIP1 contributes to clear cell renal cell carcinomas development.

Authors:  Janusz Ligeza; Paulina Marona; Natalia Gach; Barbara Lipert; Katarzyna Miekus; Waclaw Wilk; Janusz Jaszczynski; Andrzej Stelmach; Agnieszka Loboda; Jozef Dulak; Wojciech Branicki; Janusz Rys; Jolanta Jura
Journal:  Angiogenesis       Date:  2017-02-14       Impact factor: 9.596

4.  Hypoxia regulates CD9-mediated keratinocyte migration via the P38/MAPK pathway.

Authors:  Xupin Jiang; Xiaowei Guo; Xue Xu; Miao Teng; Chong Huang; Dongxia Zhang; Qiong Zhang; Jiaping Zhang; Yuesheng Huang
Journal:  Sci Rep       Date:  2014-09-09       Impact factor: 4.379

5.  ERK and p38 Upregulation versus Bcl-6 Downregulation in Rat Kidney Epithelial Cells Exposed to Prolonged Hypoxia.

Authors:  Fengbao Luo; Jian Shi; Qianqian Shi; Xiaozhou He; Ying Xia
Journal:  Cell Transplant       Date:  2017-08       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.